M&A Deal Summary |
|
|---|---|
| Date | 2010-11-08 |
| Target | GISH Biomedical |
| Sector | Medical Products |
| Buyer(s) | Sorin |
| Sellers(s) | VM Capital |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2004 |
| Sector | Medical Products |
| Employees | 3,814 |
| Revenue | 782M EUR (2013) |
Sorin SpA is a developer and distributor of medical devices.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Medical Products) | 1 of 1 |
| Type (Add-on Acquisition) | 1 of 2 |
| State (California) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2010) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-11-19 |
Bellco Società unipersonale a r.l
Mirandola, Italy Bellco Società unipersonale a r.l is a provider of hemodialysis treatment solutions. Bellco offers therapies and systems for the treatment of renal failure, multiple organ failure and sepsis. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-11-12 |
Neurotech SA
Louvain-la-Neuve, Belgium Neurotech designs and develops implantable medical devices for the treatment of debilitating disorders by neurostimulation. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 675M EUR |
| Size | Middle-Market |
| Type | Sector Agnostic |
VM Capital (formerly known as Ventizz Capital Partners) is a private equity firm that targets investments in growth-oriented technology businesses operating throughout Europe. VM Capital will consider investing in individual companies as well as acquisitions of secondary private equity transactions. Specific sectors of interest include renewable energy/clean technology, semiconductors, electronics, photonics, materials applicaton, industrial automation, medical technology, IT, and communications. Vorndran looks for control stakes when making investments. The Firm's investment horizon is 3 to 6 years. VM Capital was formed in 2000 and is based in Dusseldorf.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 19 |
| Sector (Medical Products) | 2 of 3 |
| Type (Add-on Acquisition) | 3 of 6 |
| State (California) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2010) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-10-20 |
1366 Technologies
Lexington, Massachusetts, United States 1366 Technologies, based in Lexington (MA, USA) eliminates the cost and production challenges that have hampered solar power's ability to replace fossil fuels. The company combines breakthrough innovations in silicon cell architecture with lean manufacturing processes to make the worlds most cost effective and commercially viable high efficiency solar cells. Developed by a veteran team of scientists, engineers and entrepreneurs, including MIT professor and photovoltaic industry expert Dr. Emanuel Sachs, the company's novel approach breaks the historic efficiency and cost tradeoff of photovoltaics. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-01-27 |
ersol Solar Energy AG
Erfurt, Germany The ersol group is a leading manufacturer and distributor for photovoltaic products. After acquiring ASi Industries GmbH, ersol focuses on value chain segments of ingot and wafer production (ASi GmbH) and the production of solar cells (ersol AG). In addition, the ersol group is also involved in module production (via its joint venture SESE Co. Ltd.) to a minor extent and its subsidiary aimex-solar GmbH also trades modules. |
Sell | - |
